Patents by Inventor Christine Andreoni

Christine Andreoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules
    Publication number: 20050181484
    Abstract: The present application relates to a method for obtaining mastocyte cultures or lines. It also relates to a method for producing heparin-type molecules, comprising the culturing of mastocyte cultures or lines.
    Type: Application
    Filed: April 13, 2004
    Publication date: August 18, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Jean-Marc Guillaume, Werner Dittrich, Sandrine Perez, Christine Andreoni, Romain Paillot
  • Complexes of immunogens derived from RSV surface glycoprotein G covalently coupled to a support molecule
    Patent number: 6558673
    Abstract: A complex of an immunogen and a support molecule, characterized in that the immunogen is coupled covalently to a support molecule, wherein the support molecule is a polypeptide fragment which is able to bind specifically to mammalian serum albumin is disclosed. The invention also relates to the use of such complexes to treat RSV infection, as well as vaccines derived from such complexes.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: May 6, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc Nguyen, Christine Andreoni, Ake Per Nygren, Stefan Stahl, Mathias Uhlen
  • Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
    Patent number: 6149911
    Abstract: The present invention relates to a process for improving the immunogenicity of an immunogen, an antigen or a hapten, when it is administered to a host, independently of the mode of administration, characterized in that the said antigen or hapten is coupled covalently to a support molecule in order to form a complex, and in that this support molecule is a polypeptide fragment which is able to bind specifically to mammalian serum albumin. The invention also relates to the use, as a medicament, of the product which can be obtained in this way.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: November 21, 2000
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Nguyen Ngoc, Christine Andreoni, Per Ake Nygren, Stefan Stahl, Mathias Uhlen